BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 24982387)

  • 1. Third-line trabectedin for a metastatic desmoplastic small round cell tumour treated with multimodal therapy.
    Brunetti AE; Delcuratolo S; Lorusso V; Palermo L; Di Giorgio A; Pisconti S; Silvestris N
    Anticancer Res; 2014 Jul; 34(7):3683-8. PubMed ID: 24982387
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trabectedin in advanced desmoplastic round cell tumors: a retrospective single-center series.
    Verret B; Honore C; Dumont S; Terrier P; Adam J; Cavalcanti A; Sourrouille I; Klausner G; Ahlenc-Gelas M; Kiavue N; Domitrescu G; El Amarti L; Mir O; Le Cesne A
    Anticancer Drugs; 2017 Jan; 28(1):116-119. PubMed ID: 27782906
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanism of action of trabectedin in desmoplastic small round cell tumor cells.
    Uboldi S; Craparotta I; Colella G; Ronchetti E; Beltrame L; Vicario S; Marchini S; Panini N; Dagrada G; Bozzi F; Pilotti S; Galmarini CM; D'Incalci M; Gatta R
    BMC Cancer; 2017 Feb; 17(1):107. PubMed ID: 28166781
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activity of trabectidin in desmoplastic small round cell tumor.
    López-González A; Cantos B; Tejerina E; Provencio M
    Med Oncol; 2011 Dec; 28 Suppl 1():S644-6. PubMed ID: 20924717
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intra-Abdominal Desmoplastic Small Round Cell Tumor (DSRCT) and the Role of Hyperthermic Intraperitoneal Chemotherapy (HIPEC): A Review.
    Reijers SJM; Siew CCH; Kok NFM; Honoré C; van Houdt WJ
    Curr Oncol; 2023 Mar; 30(4):3951-3963. PubMed ID: 37185412
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trabectedin-irinotecan, a potentially promising combination in relapsed desmoplastic small round cell tumor: report of two cases.
    Ferrari A; Chiaravalli S; Bergamaschi L; Nigro O; Livellara V; Sironi G; Gasparini P; Pasquali S; Zaffaroni N; Stacchiotti S; Morosi C; Massimino M; Casanova M
    J Chemother; 2023 Apr; 35(2):163-167. PubMed ID: 35470779
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Desmoplastic small-round-cell tumor of the peritoneum: An uncommon entity with poor prognosis].
    Palomeque Jiménez A; Pérez Cabrera B; González Puga C; Navarro Freire F; Jiménez Ríos JA
    Gastroenterol Hepatol; 2015; 38(6):383-5. PubMed ID: 24996875
    [No Abstract]   [Full Text] [Related]  

  • 8. Trabectedin has promising antineoplastic activity in high-grade meningioma.
    Preusser M; Spiegl-Kreinecker S; Lötsch D; Wöhrer A; Schmook M; Dieckmann K; Saringer W; Marosi C; Berger W
    Cancer; 2012 Oct; 118(20):5038-49. PubMed ID: 22392434
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Response to trabectedin treatment in a highly pretreated patient with an advanced meningeal hemangiopericytoma.
    Martinez-Trufero J; Alfaro J; Felipo F; Alvarez M; Madani J; Cebollero A
    Anticancer Drugs; 2010 Sep; 21(8):795-8. PubMed ID: 20622667
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stable disease in a patient with metastatic leiomyosarcoma treated with trabectedin.
    Tavella K; Villanucci A; Vannini L; Lavacchi D; Montelatici S; Amunni G; Mazzei T
    Anticancer Drugs; 2017 Apr; 28(4):465-468. PubMed ID: 28181940
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trabectedin for desmoplastic small round cell tumours: a possible treatment option?
    Frezza AM; Whelan JS; Dileo P
    Clin Sarcoma Res; 2014; 4():3. PubMed ID: 24829745
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A retrospective analysis of antitumour activity with trabectedin in translocation-related sarcomas.
    Le Cesne A; Cresta S; Maki RG; Blay JY; Verweij J; Poveda A; Casali PG; Balaña C; Schöffski P; Grosso F; Lardelli P; Nieto A; Alfaro V; Demetri GD
    Eur J Cancer; 2012 Nov; 48(16):3036-44. PubMed ID: 22749255
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduced toxicity with intensity modulated radiation therapy (IMRT) for desmoplastic small round cell tumor (DSRCT): an update on the whole abdominopelvic radiation therapy (WAP-RT) experience.
    Desai NB; Stein NF; LaQuaglia MP; Alektiar KM; Kushner BH; Modak S; Magnan HM; Goodman K; Wolden SL
    Int J Radiat Oncol Biol Phys; 2013 Jan; 85(1):e67-72. PubMed ID: 23084475
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prolonged disease stability with trabectedin in a heavily pretreated elderly patient with metastatic leiomyosarcoma of the thigh and renal failure: a case report and review of the literature.
    Galizia D; Palesandro E; Nuzzo AM; Pignochino Y; Aliberti S; Aglietta M; Grignani G
    Oncol Res; 2013; 20(10):483-90. PubMed ID: 24308159
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trabectedin in advanced uterine leiomyosarcomas: a retrospective case series analysis from two reference centers.
    Sanfilippo R; Grosso F; Jones RL; Banerjee S; Pilotti S; D'Incalci M; Dei Tos AP; Raspagliesi F; Judson I; Casali PG
    Gynecol Oncol; 2011 Dec; 123(3):553-6. PubMed ID: 21917307
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Danish experience with trabectedin treatment for metastatic sarcoma: Importance of hyponatremia.
    Schack LH; Mouritsen LS; Elowsson C; Krarup-Hansen A; Safwat A
    Acta Oncol; 2015 Jan; 54(1):34-40. PubMed ID: 25263179
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of response evaluation criteria in solid tumours and Choi criteria for response evaluation in patients with advanced soft tissue sarcoma treated with trabectedin: a retrospective analysis.
    Taieb S; Saada-Bouzid E; Tresch E; Ryckewaert T; Bompas E; Italiano A; Guillemet C; Peugniez C; Piperno-Neumann S; Thyss A; Maynou C; Clisant S; Penel N;
    Eur J Cancer; 2015 Jan; 51(2):202-9. PubMed ID: 25499439
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complete response of a recurrent-metastatic liposarcoma with dedifferentiated histological features following the administration of trabectedin and review of literature.
    Kus T; Aktas G; Kalender ME; Tutar E; Ulker E; Camci C
    J Cancer Res Ther; 2015; 11(4):974-6. PubMed ID: 26881560
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trabectedin for advanced soft tissue sarcomas: a single institution experience.
    Gounaris I; Hatcher HM; Davidson D; Sherbourne K; Alam S; Zaki KA; Horan G; Earl HM
    Future Oncol; 2014 Aug; 10(11):1843-51. PubMed ID: 24450573
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trabectedin in patients with metastatic soft tissue sarcoma: a retrospective single center analysis.
    Schur S; Lamm W; Köstler WJ; Hoetzenecker K; Nemecek E; Schwameis K; Klepetko W; Windhager R; Brodowicz T
    Anticancer Drugs; 2013 Aug; 24(7):725-30. PubMed ID: 23728219
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.